Neurogastrx
2012
FOUNDED
PRIVATE
STATUS
Series A
LATEST DEAL TYPE
$45M
LATEST DEAL AMOUNT
3
INVESTORS
Description
Provider of biopharmaceutical research and development services designed to treat gastrointestinal disorders affecting the enteric nervous system. The company's biopharmaceutical research and development services addresses unmet needs of functional and motility gastrointestinal disorders, enabling patients to get relief from bowel disorders.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Primary Office
- 1608 West Campbell Avenue
- Suite 210
- Campbell, CA 95008
- United States
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Neurogastrx’s full profile, request a free trial.
Neurogastrx Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A) | 01-Aug-2018 | $45M | 000.00 | 000.00 | Completed | Generating Revenue |
| 2. Seed Round | 12-Sep-2016 | 00000 | 00.000 | 000 | Completed | Generating Revenue |
| 1. Convertible Debt | 01-Apr-2014 | $2M | $2M | Completed | Generating Revenue |
Neurogastrx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 00,000,000 | 00.000000 | 00 | 00.0 | 00.0 | 00 | 00.0 | 00.000 |
| Seed | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
Neurogastrx Competitors (9)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Synergy Pharmaceuticals | Formerly PE-Backed | New York, NY | 000 | 00000 | 000000&0 | |
| 00000000 000000000 | Corporate Backed or Acquired | Cambridge, MA | 000 | 00000 | 000000000 | 00000 |
| 00000000 | Venture Capital-Backed | Mill Valley, CA | 0000 | 00000000000 | 0000 | |
| 000000 000000000 | Formerly Angel backed | New York, NY | 00 | 00.000 | 00000000 | 00.000 |
| 000000000 000000 | Formerly VC-backed | Cambridge, MA | 000 | 00000 | 00000000 | 00000 |
Neurogastrx Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| 5AM Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| OrbiMed | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| venBio | Venture Capital | Minority | 000 0000 | 000000 0 |
Neurogastrx Executive Team (5)
2 Former Executives
You’re viewing 3 of 5 executives. Get the full list »Neurogastrx Board Members (6)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Aaron Royston MD | venBio | Board Member | 000 0000 | |
| David Allison Ph.D | 5AM Ventures | Board Member | 000 0000 | |
| Kevin Koch Ph.D | OrbiMed | Board Member | 000 0000 | |
| Klaus Veitinger Ph.D | OrbiMed | Chairman | 000 0000 | |
| Willie Quinn | Self | Board Member | 000 0000 |
1 Former Board Member
You’re viewing 5 of 6 board members. Get the full list »